Royal Philips
(Image from Royal Philips)
Royal Philips (NYSE:PHG) announced the launch of its IntelliSpace AI workflow platform with for imaging. It includes applications for integration of existing department and hospital infrastructure and is designed to automatically route clinical data to the appropriate AI application for data analysis without user interaction, and then display the results. The platform can work with Philips diagnostic imaging and informatics systems as well as with other vendors’ software.
Philips IntelliSpace AI Workflow Suite is launching with:
- Aidoc applications for intracranial hemorrhage, C-spine fractures and pulmonary embolism.
- MaxQ AI applications such as that company’s Accipio intracranial hemorrhage and stroke platform.
- Quibim applications for brain lesion detection, chest X-ray classifier, emphysema, liver fat and iron concentration, and brain atrophy analysis.
- Riverain Technologies’ applications such as it ClearRead bone suppression and ClearRead CT.
- Zebra Medical applications including intracranial hemorrhage and pneumothorax.
Leiden University Medical Center in the Netherlands recently signed an agreement to be the first healthcare provider to install the platform.
